Manager, Marketing I​/II Oncology

• Compensation: USD 124,500 - USD 236,500 - yearly

About Abb Vie

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  .

Follow @abbvie on Linked In, Facebook , Instagram , X and You Tube.

The Marketing Manager I/II – DTC Patient Marketing will be a key driver of Elahere direct-to-consumer and patient-facing marketing strategies. Elahere is the first FDA-approved ADC for FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer — representing a transformative therapy for a patient population with significant unmet need.

This role is responsible for developing, executing, and optimizing patient-directed promotional programs and multichannel campaigns that meaningfully connect women living with platinum-resistant ovarian cancer to information about Elahere and FRα testing. The MMI/II will serve as a critical connector between patient insights, brand strategy, HCP marketing, and media execution — bringing the patient voice to the forefront of the Elahere brand.

Key Responsibilities

• Develop and execute integrated, multichannel DTC patient marketing plans in alignment with overall Elahere brand strategy, ensuring consistency across paid media, owned channels, digital platforms, and patient support programs.
• Lead development of patient-facing promotional materials including digital advertising, social media content, disease awareness campaigns, and patient ambassador/testimonial programs, from brief through regulatory approval and launch.
• Champion patient-centric messaging rooted in the Elahere efficacy and safety story, including OS benefit (median 16.5 months vs. 12.7 months vs. chemotherapy) and the importance of FRα biomarker testing as a gateway to treatment eligibility.
• Develop DTC messaging frameworks that address the emotional and clinical journey of women with platinum-resistant ovarian cancer — including recurrence, treatment decision-making, and communicating with their oncologist.
• Partner with digital/media agencies to plan, activate, and optimize paid digital campaigns (search, display, social, programmatic, CRM/email, and streaming/video).
• Manage patient website content strategy and SEO/SEM initiatives in alignment with brand guidelines and regulatory requirements.
• Utilize data and analytics to monitor campaign KPIs — including reach, site traffic, patient activation rates, and script lift — and translate performance data into actionable optimization recommendations.

Patient Support & Access Integration

• Collaborate with patient services, market access, and Halo (Abb Vie's patient support program) teams to ensure seamless integration of DTC patient acquisition tactics with downstream support enrollment and adherence programs.
• Develop communications that address patient barriers, including FRα testing access, out-of-pocket costs, and ocular toxicity management guidance for patients.

Cross-Functional Collaboration

• Partner closely with HCP marketing to develop aligned messaging architectures that reinforce the provider-patient dialogue around Elahere — particularly regarding FRα testing and treatment selection.
• Collaborate cross-functionally with Medical Affairs, Regulatory, Legal, Market Research, and Patient Advocacy to ensure all DTC materials are compliant, scientifically accurate, and patient-centered.
• Serve as the patient marketing lead on the…